View Related Documents

Abstract

(1) The mean cumulative urinary digoxin excretion over 8 days was compared in 8 healthy volunteers after single doses of digoxin administered as 3 Lanoxin tablets of 0.25 mg, 3 digoxin tablets of 0.2 mg, 12 Lanoxicaps without sorbitol of 0.05 mg, 6 Lanoxicaps without sorbitol of 0.1 mg digoxin, 3 Lanoxicaps without sorbitol of 0.2 mg and 3 Lanoxicaps with sorbitol of 0.2 mg. (2) There was no significant difference between the 8 day cumulative urinary excretion for any of the Lanoxicaps treatments. (3) Cumulative urinary excretion after 3 digoxin tablets of 0.2 mg was significantly (P<0.05) lower="" than="" after="" all="" other="" treatments.="" (4)="" cumulative="" urinary="" excretion="" after="" 3="" lanoxin="" tablets="" of="" 0.25="" mg="" was="" not="" significantly="" different="" from="" that="" after="" any="" of="" the="" lanoxicaps="" treatments="" except="" 0.1="" mg="" lanoxicaps="" without="" sorbitol,="" it="" was="" significantly=""><0.05) lower="" after="" the="" latter.="" (5)="" mean="" urinary="" excretion="" of="" digoxin="" was="" 60%="" of="" ingested="" dose="" for="" all="" lanoxicaps="" treatments="" and="" was="" significantly=""><0.05) higher="" than="" the="" mean="" value="" of="" 50%="" for="" both="" tablet="" treatments.="" (6)="" enhanced="" absorption="" of="" digoxin="" from="" lanoxicaps="" was="" confirmed="" and="" shown="" to="" be="" unrelated="" to="" the="" sorbitol="" content="" of="" the="" capsule="">

Key words  Lanoxin tablets - Lanoxicaps - sorbitol - bioavailability

Trade marks

Fulltext Preview

Image of the first page of the fulltext document